Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo-Induced Cross-Linking of Unmodified Proteins

Methods in Enzymology

Volumn 413, Issue , 2006, Pages 217-236

  Bitan, Gal ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER;

CROSS LINKING; CYTOTOXICITY; ENZYME INHIBITION; OLIGOMERIZATION; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW;

2,2'-DIPYRIDYL; AMYLOID; AMYLOID BETA-PROTEIN; CALCITONIN; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GROWTH HORMONE-RELEASING HORMONE; PEPTIDE FRAGMENTS; PHOTOCHEMISTRY; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY;

EID: 33749518696     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)13012-8     Document Type: Review

References (62)

1. Baillat D., Begue A., Stehelin D., and Aumercier M. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J. Biol. Chem. 277 (2002) 29386-29398
2. Beernink H.T., and Morrical S.W. The uvsY recombination protein of bacteriophage T4 forms hexamers in the presence and absence of single-stranded DNA. Biochemistry 37 (1998) 5673-5681
3. Bitan G., Fradinger E.A., Spring S.M., and Teplow D.B. Neurotoxic protein oligomers-what you see is not always what you get. Amyloid 12 (2005) 88-95
4. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100 (2003) 330-335
5. Bitan G., Lomakin A., and Teplow D.B. Amyloid β-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276 (2001) 35176-35184
6. 35 and amyloid β-protein oligomerization. J. Am. Chem. Soc. 125 (2003) 15359-15365
7. Bitan G., and Teplow D.B. Rapid photochemical cross-linking-a new tool for studies of metastable, amyloidogenic protein assemblies. Acc. Chem. Res. 37 (2004) 357-364
8. Bitan G., and Teplow D.B. Preparation of aggregate-free, low molecular weight Aβ for assembly and toxicity assays. In: Sigurdsson E.M. (Ed). "Amyloid Proteins-Methods and Protocols" Vol. 299 (2005), Humana Press, Totawa, NJ 3-10
9. Bitan G., Vollers S.S., and Teplow D.B. Elucidation of primary structure elements controlling early amyloid β-protein oligomerization. J. Biol. Chem. 278 (2003) 34882-34889
10. Bjerrum M.J., Casimiro D.R., Chang I.J., Di Bilio A.J., Gray H.B., Hill M.G., Langen R., Mines G.A., Skov L.K., Winkler J.R., and Wuttke D.S. Electron transfer in ruthenium-modified proteins. J. Bioenerg. Biomembr. 27 (1995) 295-302
11. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J.S., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
12. Buxbaum J. The amyloidoses. Mt. Sinai J. Med. 63 (1996) 16-23
13. Buxbaum J.N. The systemic amyloidoses. Curr. Opin. Rheumatol. 16 (2004) 67-75
14. Buxbaum J.N., and Tagoe C.E. The genetics of the amyloidoses. Annu. Rev. Med. 51 (2000) 543-569
15. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., and Dobson C.M. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl. Acad. Sci. USA 99 (2002) 16419-16426
16. Cleverley R.M., and Gierasch L.M. Mapping the signal sequence-binding site on SRP reveals a significant role for the NG domain. J. Biol. Chem. 277 (2002) 46763-46768
17. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., and Lansbury P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 571-576
18. Crouch P.J., Blake R., Duce J.A., Ciccotosto G.D., Li Q.X., Barnham K.J., Curtain C.C., Cherny R.A., Cappai R., Dyrks T., Masters C.L., and Trounce I.A. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42. J. Neurosci. 25 (2005) 672-679
19. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-b peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
20. Das M., and Fox C.F. Chemical cross-linking in biology. Annu. Rev. Biophys. Bioeng. 8 (1979) 165-193
21. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
22. Duroux-Richard I., Vassault P., Subra G., Guichou J.F., Richard E., Mouillac B., Barberis C., Marie J., and Bonnafous J.C. Crosslinking photosensitized by a ruthenium chelate as a tool for labeling and topographical studies of G-protein-coupled receptors. Chem. Biol. 12 (2005) 15-24
23. El-Agnaf O.M., Nagala S., Patel B.P., and Austen B.M. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J. Mol. Biol. 310 (2001) 157-168
24. Fancy D.A. Elucidation of protein-protein interactions using chemical cross-linking or label transfer techniques. Curr. Opin. Chem. Biol. 4 (2000) 28-33
25. Fancy D.A., Denison C., Kim K., Xie Y.Q., Holdeman T., Amini F., and Kodadek T. Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes. Chem. Biol. 7 (2000) 697-708
26. Fancy D.A., and Kodadek T. Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl. Acad. Sci. USA 96 (1999) 6020-6024
27. Fezoui Y., Hartley D.M., Harper J.D., Khurana R., Walsh D.M., Condron M.M., Selkoe D.J., Lansbury P.T., Fink A.L., and Teplow D.B. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments. Amyloid 7 (2000) 166-178
28. Gambetti P., and Russo C. Human brain amyloidoses. Nephrol. Dial. Transplant 13 (1998) 33-40
29. Hardy J. Testing times for the "amyloid cascade hypothesis.". Neurobiol. Aging 23 (2002) 1073-1074
30. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297 (2002) 353-356
31. Hardy J.A., and Higgins G.A. Alzheimer's disease: The amyloid cascade hypothesis. Science 256 (1992) 184-185
32. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., and Sato K. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. USA 100 (2003) 6370-6375
33. Jacobsen S., Wittig M., and Poggeler S. Interaction between mating-type proteins from the homothallic fungus Sordaria macrospora. Curr. Genet. 41 (2002) 150-158
34. Kalyanasundaram K. Photophysics, photochemistry and solar energy conversion with tris(bipyridyl)ruthenium(II) and its analogues. Coord. Chem. Rev. 46 (1982) 159-244
35. Kim K., Fancy D.A., Carney D., and Kodadek T. Photoinduced protein cross-linking mediated by palladium porphyrins. J. Am. Chem. Soc. 121 (1999) 11896-11897
36. Kirkitadze M.D., Bitan G., and Teplow D.B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69 (2002) 567-577
37. Kluger R., and Alagic A. Chemical cross-linking and protein-protein interactions-a review with illustrative protocols. Bioorg. Chem. 32 (2004) 451-472
38. Knorre D.G., and Godovikova T.S. Photoaffinity labeling as an approach to study supramolecular nucleoprotein complexes. FEBS Lett. 433 (1998) 9-14
39. Kotzyba-Hibert F., Kapfer I., and Goeldner M. Recent trends in photoaffinity labeling. Angew. Chem. Int. Ed. Engl. 34 (1995) 1296-1312
40. Lazo N.D., Maji S.K., Fradinger E.A., Bitan G., and Teplow D.B. The Amyloid β-Protein. In: Sipe J.D. (Ed). "Amyloid Proteins-The β-Sheet Conformation and Disease" Vol. 1 (2005), Wiley-VCH, Weinheim 385-448
41. LeVine III H. Alzheimer's β-peptide oligomer formation at physiologic concentrations. Anal. Biochem. 335 (2004) 81-90
42. Lin H.J., and Kodadek T. Photo-induced oxidative cross-linking as a method to evaluate the specificity of protein-ligand interactions. J. Pept. Res. 65 (2005) 221-228
43. Luebke K.J., Carter D.E., Garner H.R., and Brown K.C. Patterning adhesion of mammalian cells with visible light, tris(bipyridyl)ruthenium(II) chloride, and a digital micromirror array. J. Biomed. Mater. Res. A 68 (2004) 696-703
44. Lumb M.J., and Danpure C.J. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J. Biol. Chem. 275 (2000) 36415-36422
45. Malisauskas M., Ostman J., Darinskas A., Zamotin V., Liutkevicius E., Lundgren E., and Morozova-Roche L.A. Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?. J. Biol. Chem. 280 (2005) 6269-6275
46. Marzban L., Park K., and Verchere C.B. Islet amyloid polypeptide and type 2 diabetes. Exp. Gerontol. 38 (2003) 347-351
47. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
48. Meunier S., Strable E., and Finn M.G. Crosslinking of and coupling to viral capsid proteins by tyrosine oxidation. Chem. Biol. 11 (2004) 319-326
49. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
50. Nordstedt C., Näslund J., Tjernberg L.O., Karlstrom A.R., Thyberg J., and Terenius L. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269 (1994) 30773-30776
51. Paoli P., Giannoni E., Pescitelli R., Camici G., Manao G., and Ramponi G. Hydrogen peroxide triggers the formation of a disulfide dimer of muscle acylphosphatase and modifies some functional properties of the enzyme. J. Biol. Chem. 276 (2001) 41862-41869
52. Reixach N., Deechongkit S., Jiang X., Kelly J.W., and Buxbaum J.N. Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl. Acad. Sci. USA 101 (2004) 2817-2822
53. Selkoe D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
54. Shen W.J., Patel S., Hong R., and Kraemer F.B. Hormone-sensitive lipase functions as an oligomer. Biochemistry 39 (2000) 2392-2398
55. Thirumalai D., Klimov D.K., and Dima R.I. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13 (2003) 146-159
56. Trojanowski J.Q., and Mattson M.P. Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses. Neuromolecular Med. 4 (2003) 1-6
57. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid β-protein fibrillogenesis-detection of a protofibrillar intermediate. J. Biol. Chem. 272 (1997) 22364-22372
58. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
59. Walsh D.M., and Selkoe D.J. Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 11 (2004) 213-228
60. Wang R., Sweeney D., Gandy S.E., and Sisodia S.S. The profile of soluble amyloid β protein in cultured cell media. Detection and quantification of amyloid β protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271 (1996) 31894-31902
61. Wiltfang J., Esselmann H., Bibl M., Smirnov A., Otto M., Paul S., Schmidt B., Klafki H.W., Maler M., Dyrks T., Bienert M., Beyermann M., Ruther E., and Kornhuber J. Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J. Neurochem. 81 (2002) 481-496
62. Wolf J., Gerber A.P., and Keller W. tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli. EMBO J. 21 (2002) 3841-3851